(continued)
Dr. Hood commented that "Cellumen has assembled a terrific set of technologies, advisors and collaborators to optimize the commercialization of cellular systems biology".
Cellumen is the Cellular Systems Biology Company that is focusing on the cell as an integrated and interacting network of genes, proteins and metabolites that are responsible for normal and abnormal functions. Cellumen is directly pursuing the two main issues of efficacy and toxicity that limit the efficiency of drug discovery. The Cellumen products and services address "cellular models of disease", "cytotoxicity profiling" and "patient sample profiling". Cellumen leverages the experience and expertise in High Content Screening, as well as advanced reagents and informatics to create high value solutions. Further information can be found at www.cellumen.com